MRC, in partnership with the DH, Wellcome Trust, CRUK, BHF, ARUK and Research Councils are seeking expressions of interest from internationally recognised institutions with a proven track record in cutting-edge clinical research. Discussions are also on-going with devolved administrations about the potential for partnership funding.
The overall objectives of this initiative will be to support innovation in clinical research - funding the novel technologies and facilities, which will most effectively advance the UK’s ability to explore new areas in clinical research, and to enhance translational capability and partnerships with industry.
The call will be organised around three themes:
1. Innovative technologies for stratified and experimental medicine (including clinical sensing & imaging and ex vivo analysis).
2. Dementia research. As well as public sector funding for the UK Dementia Platform (Neurodegeneration Programme), partners will consider discrete proposals for other clinical research technology enhancements for dementia and neurodegeneration.
3. Single cell-level functional genomics
Expressions of interest are invited by 7 January 2014 with funding decisions made in July for spend in 2015/16.